[Treatment of cardiac complications in hyperthyroidism].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy* / Q000209:etiology; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000188:drug therapy; D008750:Methyldopa / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D013565:Sympatholytics; D008750:Methyldopa; D012110:Reserpine; D006145:Guanethidine
Le traitement des complications cardiaques de l'hyperthyroïdie.